3 y 6 cuotas sin interés en toda la web
Envíos en el día a CABA y AMBA comprando antes del mediodía
$369.000,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

Advances in Clinical Chemistry, Volume 119, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. Topics covered in this new release include Advances in Endotoxin Analysis, SARS-CoV-2 detection and surveillance, Osteopontin in Cancer, Gastrointestinal Hormones: History, Biology, and Measurement, Natriuretic Peptide Testing Strategies in Heart Failure: a 2023 Update, and Defining Allowable Total Error Limits in the Clinical Laboratory.

  • Provides the most up-to-date technologies in clinical chemistry and clinical laboratory science
  • Authored by world renowned clinical laboratory scientists, physicians, and research scientists
  • Presents the international benchmark for novel analytical approaches in the clinical laboratory

1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Contributors - p. iii 6. Preface - p. iii 7. Chapter One: Extracellular vesicles in heart failure - p. 2 8. Chapter Two: Biomarkers of minimal residual disease and treatment - p. 34 9. Chapter Three: Myocardial fibrosis in right heart dysfunction - p. 73 10. Chapter Four: Advances in sepsis biomarkers - p. 118 11. Chapter Five: Advances in familial hypercholesterolemia - p. 168 12. Index - p. 201

Descripcion
Descripción

Advances in Clinical Chemistry, Volume 119, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. Topics covered in this new release include Advances in Endotoxin Analysis, SARS-CoV-2 detection and surveillance, Osteopontin in Cancer, Gastrointestinal Hormones: History, Biology, and Measurement, Natriuretic Peptide Testing Strategies in Heart Failure: a 2023 Update, and Defining Allowable Total Error Limits in the Clinical Laboratory.

  • Provides the most up-to-date technologies in clinical chemistry and clinical laboratory science
  • Authored by world renowned clinical laboratory scientists, physicians, and research scientists
  • Presents the international benchmark for novel analytical approaches in the clinical laboratory

1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Contributors - p. iii 6. Preface - p. iii 7. Chapter One: Extracellular vesicles in heart failure - p. 2 8. Chapter Two: Biomarkers of minimal residual disease and treatment - p. 34 9. Chapter Three: Myocardial fibrosis in right heart dysfunction - p. 73 10. Chapter Four: Advances in sepsis biomarkers - p. 118 11. Chapter Five: Advances in familial hypercholesterolemia - p. 168 12. Index - p. 201

Indice
Autores
Muestra
Ficha Técnica